Mican Technologies
Kyoto, JP · 3 known investors
MiCAN Technologies produces immortalized blood cells (erythroid and myeloid-lineage cells) using regenerative medicine technology, supplying research-use blood-like cells, evaluation kits, and contract testing services. Its products serve infectious disease research and the efficacy/safety evaluation of pharmaceuticals and functional materials, including a pyrogen (fever-inducing substance) alternative testing kit.
Founders & leadership
KM
Kazuo Miyazaki代表取締役CEO (Representative Director & CEO)
KF
Kazuhisa Fushihara取締役CFO (Director & CFO)
Board
YN
Yasuhiro Natsume取締役 (Director)
Investors · 3
Frequently asked questions
- What does Mican Technologies do?
- MiCAN Technologies produces immortalized blood cells (erythroid and myeloid-lineage cells) using regenerative medicine technology, supplying research-use blood-like cells, evaluation kits, and contract testing services. Its products serve infectious disease research and the efficacy/safety evaluation of pharmaceuticals and functional materials, including a pyrogen (fever-inducing substance) alternative testing kit.
- Who are Mican Technologies's investors?
- Mican Technologies's investors include Kobe University Capital, OSAKA University Venture Capital, UntroD Capital.
- Where is Mican Technologies headquartered?
- Mican Technologies is headquartered in Kyoto, JP.